ANN CRIBBIN: Open Payments
NPI 1215529870 · BALLWIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 28 payments from 9 companies in 2025. Trend: 2023 $532 · 2024 $799 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $194 |
| Amgen Inc. | 5 | $107 |
| Exact Sciences Corporation | 5 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| Lilly USA, LLC | 1 | $19 |
| PFIZER INC. | 1 | $16 |
Products named: OTEZLA, UBRELVY, Cologuard Collection Kit, QULIPTA, Symbravo, SHINGRIX, INSPIRE, VRAYLAR.
Industry payments across MO — which companies pay providers there.
